Medivation Announces Participation at Upcoming Investor Conferences
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 11/07/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:
Patrick Machado, chief business and financial officer, will present at the Jefferies 2012 Global Healthcare Conference on November 14 at 3:00p.m. in London.
David Hung, M.D., president and chief executive officer, will present at the Credit Suisse 2012 Healthcare Conference on November 14 at 11:30a.m. in Phoenix, AZ.
David Hung, M.D., president and chief executive officer, will present at the 24th Annual Piper Jaffray Healthcare Conference on November 27 at noon in New York, NY.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at .
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.11.2012 - 21:49 Uhr
Sprache: Deutsch
News-ID 200783
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 187 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Announces Participation at Upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
